OBJECTIVES: To determine the prognostic potential of S100B protein in patients with craniocerebral injury, correlation between S100B protein and time, selected internal diseases, body habitus, polytrauma, and season. METHODS: We examined the levels of S100B protein in 124 patients with traumatic brain injury (TBI). RESULTS: The S100B protein level 72 h after injury and changes over 72 h afterwards are statistically significant for prediction of a good clinical condition 1 month after injury. The highest sensitivity (81.4%) and specificity (83.3%) for the S100B protein value after 72 h was obtained for a cut-off value of 0.114. For the change after 72 h, that is a decrease in S100B value, the optimal cut-off is 0.730, where the sum of specificity (76.3%) and sensitivity (54.2%) is the highest, or a decrease by 0.526 at the cut-off value, where sensitivity (62.5%) and specificity (62.9%) are more balanced. The S100B values were the highest at baseline; S100B value taken 72 h after trauma negatively correlated with GCS upon discharge or transfer (r=-0.517, P<0.0001). We found no relationship between S100B protein and hypertension, diabetes mellitus, BMI, or season when the trauma occurred. Changes in values and a higher level of S100B protein were demonstrated in polytraumas with a median of 1.070 (0.042; 8.780) μg/L compared to isolated TBI with a median of 0.421 (0.042; 11.230) μg/L. CONCLUSION: S100B protein level with specimen collection 72 h after trauma can be used as a complementary marker of patient prognosis.

Department of Neurosurgery University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

See more in PubMed

Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM, Rosenfeld JV, Park KB. Estimating the global incidence of traumatic brain injury. J Neurosurg 2018:1-18. doi: 10.3171/2017.10.JNS17352 PubMed DOI

Wijanarko F, Sungkar AA, Saadhi I, Setiawati DA. S100β protein levels as a parameter to assess the clinical development of adult patients with mild traumatic brain injury in Dr. Moewardi Public Hospital, Surakarta. Surg Neurol Int 2021;12:342. doi: 10.25259/SNI_294_2021 PubMed DOI

Janigro D, Mondello S, Posti JP, Unden J. GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask. Front Neurol 2022;13:835597. DOI

Trnka Š, Jablonský J, Stejskal P, Hrabálek L, Vaverka M, Krahulík D. Protein S100B a jeho prognostické možnosti u kraniocerebrálních traumat. Cesk Slov Neurol N 2021;84(6):562-6. (In Czech) DOI

Tateishi N, Shimoda T, Yada N, Shinagawa R, Kagamiishi Y. S100B: astrocyte specific protein. Nihon Shinkei Seishin Yakurigaku Zasshi 2006;26(1):11-6. (In Japanese)

Rezaei O, Pakdaman H, Gharehgozli K, Simani L, Vahedian-Azimi A, Asaadi S, Sahraei Z, Hajiesmaeili M. S100 B: A new concept in neurocritical care. Iran J Neurol 2017;16(2):83-9.

Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19(6):739-44. doi: 10.1016/0006-291x(65)90320-7 PubMed DOI

Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Functions of S100 proteins. Curr Mol Med 2013;13(1):24-57. DOI

Sorci G, Riuzzi F, Arcuri C, Tubaro C, Bianchi R, Giambanco I, Donato R. S100B protein in tissue development, repair and regeneration. World J Biol Chem 2013;4(1):1-12. doi: 10.4331/wjbc.v4.i1.1 PubMed DOI

Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2(7872):81-4. DOI

Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1(7905):480-4. DOI

Žurek J, Bartlová L, Marek L, Fedora M. Sérový protein S100B jako molekulární marker závažnosti poranění mozku u dětí. Cesk Slov Neurol N 2010;73/106(1):37-44. (In Czech)

Thelin EP, Johannesson L, Nelson D, Bellander BM. S100B is an important outcome predictor in traumatic brain injury. J Neurotrauma 2013;30(7):519-28. DOI

Wijanarko F, Alifianto U, Setyono H, Arsika Ramadhana G, Sungkar AA, Saadhi I, Setiawati DA. S100β protein levels as a parameter to assess the clinical development of adult patients with mild traumatic brain injury in Dr. Moewardi Public Hospital, Surakarta. Surg Neurol Int 2021;12:342. doi: 10.25259/SNI_294_2021 PubMed DOI

Marmarou A, Portella G, Barzo P, Signoretti S, Fatouros P, Beaumont A, Jiang T, Bullock R. Distinguishing between cellular and vasogenic edema in head injured patients with focal lesions using magnetic resonance imaging. Acta Neurochir Suppl 2000;76:349-51. doi: 10.1007/978-3-7091-6346-7_72 PubMed DOI

Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T. S100B serum level predicts computed tomography findings after minor head injury. J Trauma 2007;62(6):1452-6. DOI

Herrmann M, Jost S, Kutz S, Ebert AD, Kratz T, Wunderlich MT, Synowitz H. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 2000;17(2):113-22. DOI

Sherstnev VV, Gruden' MA, Elistratova EI, Karlina VP, Kuznetsova AV, Ryzhova TV, Ryzhov VM, Sen'ko OV. Pre-Hypertension and Hypertension. Bull Exp Biol Med 2015;158, 604-6. DOI

Riuzzi F, Chiappalupi S, Arcuri C, Giambanco I, Sorci G, Donato R. S100 proteins in obesity: liaisons dangereuses. Cell Mol Life Sci 2020;77(1):129-47. DOI

Kheirouri S, Ebrahimi E, Alizadeh M. Association of S100B Serum Levels with Metabolic Syndrome and its Components. Acta Medica Portuguesa 2018;31(4):201-6. DOI

Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D. Extracranial sources of S100B do not affect serum levels. PloS One 2010;5(9):12691. DOI

Pfortmueller CA, Drexel C, Krähenmann-Müller S, Leichtle AB, Fiedler GM, Lindner G, Exadaktylos AK. S-100 B Concentrations Are a Predictor of Decreased Survival in Patients with Major Trauma, Independently of Head Injury. PLoS One 2016;11(3):e0152822. doi: 10.1371/journal.pone.0152822 PubMed DOI

Morera-Fumero AL, Abreu-Gonzalez P, Henry-Benitez M, Yelmo-Cruz S, Diaz-Mesa E. Summer/winter changes in serum S100B protein concentration as a source of research variance. J Psychiatr Res 2013;47(6):791-5. DOI